<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39385197</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1742-4933</ISSN><JournalIssue CitedMedium="Print"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>09</Day></PubDate></JournalIssue><Title>Immunity &amp; ageing : I &amp; A</Title><ISOAbbreviation>Immun Ageing</ISOAbbreviation></Journal><ArticleTitle>Inflammation scores based on C-reactive protein and albumin predict mortality in hospitalized older patients independent of the admission diagnosis.</ArticleTitle><Pagination><StartPage>67</StartPage><MedlinePgn>67</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">67</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12979-024-00471-y</ELocationID><Abstract><AbstractText>Systemic inflammation significantly increases the risk of short- and long-term mortality in geriatric hospitalized patients. To predict mortality in older patients with various age-related diseases and infections, including COVID-19, inflammatory biomarkers such as the C-reactive protein (CRP) to albumin ratio (CAR), and related scores and indexes, i.e. Glasgow Prognostic Score (GPS), modified GPS (mGPS), and high sensitivity (hs)-mGPS, have been increasingly utilized. Despite their easy affordability and widespread availability, these biomarkers are predominantly assessed for clinical purposes rather than predictive applications, leading to their underutilization in hospitalized older patients. In this study, we investigated the association of CAR, GPS, mGPS, and hs-mGPS with short-term mortality in 3,206 geriatric hospitalized patients admitted for acute conditions, irrespective of admission diagnosis. We observed that unit increases of CAR, and the highest classes of GPS, mGPS, and hs-mGPS were significantly associated with a two- to threefold increased risk of death, even adjusting the risk for different confounding variables. Interestingly, a hs-mGPS of 2 showed the highest effect size. Furthermore, gender analysis indicated a stronger association between all CRP-albumin based parameters and mortality in men, underscoring the gender-specific relevance of inflammation-based circulating parameters in mortality prediction. In conclusion, scores based on serum CRP and albumin levels offer additional guidance for the stratification of in-hospital mortality risk in older patients by providing additional information on the degree of systemic inflammation.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Di Rosa</LastName><ForeName>Mirko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Biostatistics and Applied Geriatric Clinical Epidemiology, IRCCS INRCA, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabbatinelli</LastName><ForeName>Jacopo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Sciences, Università Politecnica Delle Marche, Ancona, Italy. j.sabbatinelli@staff.univpm.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinic of Laboratory and Precision Medicine, IRCCS INRCA, Ancona, Italy. j.sabbatinelli@staff.univpm.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giuliani</LastName><ForeName>Angelica</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Istituti Clinici Scientifici Maugeri IRCCS, Cardiac Rehabilitation Unit of Bari Institute, Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carella</LastName><ForeName>Miriam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Complex Operative Unit of Clinical Pathology, ARNAS Civico Di Cristina e Benfratelli Hospitals, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magro</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cellular, Molecular and Clinical Pathological Laboratory, Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.N.D.), University of Palermo, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biscetti</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Unit of Neurology, IRCCS INRCA, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soraci</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Unit of Geriatric Medicine, IRCCS INRCA, Cosenza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spannella</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Sciences, Università Politecnica Delle Marche, Ancona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Internal Medicine and Geriatrics, IRCCS INRCA, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fedecostante</LastName><ForeName>Massimiliano</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Geriatria, Accettazione Geriatrica e Centro Di Ricerca Per L'invecchiamento, IRCCS INRCA, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lenci</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Unit of Nephrology and Dialysis, IRCCS INRCA, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tortato</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Diabetology Unit, IRCCS INRCA, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pimpini</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiology Unit, IRCCS INRCA, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burattini</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Internal Medicine Department, IRCCS INRCA, Osimo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecchini</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Diagnostic Imaging, Clinical and Interventional Radiology, IRCCS INRCA, Osimo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cherubini</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Sciences, Università Politecnica Delle Marche, Ancona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Geriatria, Accettazione Geriatrica e Centro Di Ricerca Per L'invecchiamento, IRCCS INRCA, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonfigli</LastName><ForeName>Anna Rita</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Scientific Direction, IRCCS INRCA, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capalbo</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IRCCS INRCA, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Procopio</LastName><ForeName>Antonio Domenico</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Sciences, Università Politecnica Delle Marche, Ancona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinic of Laboratory and Precision Medicine, IRCCS INRCA, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Balistreri</LastName><ForeName>Carmela Rita</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Cellular, Molecular and Clinical Pathological Laboratory, Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.N.D.), University of Palermo, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Olivieri</LastName><ForeName>Fabiola</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Sciences, Università Politecnica Delle Marche, Ancona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Advanced Technology Center for Aging Research, IRCCS INRCA, Ancona, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Immun Ageing</MedlineTA><NlmUniqueID>101235427</NlmUniqueID><ISSNLinking>1742-4933</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C-reactive protein</Keyword><Keyword MajorTopicYN="N">CRP-to-albumin ratio</Keyword><Keyword MajorTopicYN="N">In-hospital mortality</Keyword><Keyword MajorTopicYN="N">Older patients</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>0</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>0</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39385197</ArticleId><ArticleId IdType="pmc">PMC11463076</ArticleId><ArticleId IdType="doi">10.1186/s12979-024-00471-y</ArticleId><ArticleId IdType="pii">10.1186/s12979-024-00471-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Franceschi C, Garagnani P, Morsiani C, Conte M, Santoro A, Grignolio A, et al. The Continuum of aging and age-related diseases: common mechanisms but different rates. Front Med (Lausanne). 2018;5:61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5890129</ArticleId><ArticleId IdType="pubmed">29662881</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisano C, Polisano D, Balistreri CR, Altieri C, Nardi P, Bertoldo F, et al. Role of cachexia and fragility in the patient candidate for cardiac surgery. Nutrients. 2021;13(2):517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7915488</ArticleId><ArticleId IdType="pubmed">33562449</ArticleId></ArticleIdList></Reference><Reference><Citation>Petermann-Rocha F, Pell JP, Celis-Morales C, Ho FK. Frailty, sarcopenia, cachexia and malnutrition as comorbid conditions and their associations with mortality: a prospective study from UK Biobank. J Public Health (Oxf). 2022;44(2):e172–80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9234318</ArticleId><ArticleId IdType="pubmed">33423060</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SB, Oh JH, Park JH, Choi SP, Wee JH. Differences in youngest-old, middle-old, and oldest-old patients who visit the emergency department. Clin Exp Emerg Med. 2018;5(4):249–55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6301865</ArticleId><ArticleId IdType="pubmed">30571903</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489–95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1188185</ArticleId><ArticleId IdType="pubmed">16129869</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.</Citation><ArticleIdList><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A, Ferrucci L, Franceschi M, D’Ambrosio LP, Scarcelli C, Cascavilla L, et al. Development and validation of a multidimensional prognostic index for one-year mortality from comprehensive geriatric assessment in hospitalized older patients. Rejuvenation Res. 2008;11(1):151–61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2668166</ArticleId><ArticleId IdType="pubmed">18173367</ArticleId></ArticleIdList></Reference><Reference><Citation>Ticinesi A, Lauretani F, Nouvenne A, Porro E, Fanelli G, Maggio M, et al. C-reactive protein (CRP) measurement in geriatric patients hospitalized for acute infection. Eur J Intern Med. 2017;37:7–12.</Citation><ArticleIdList><ArticleId IdType="pubmed">27594414</ArticleId></ArticleIdList></Reference><Reference><Citation>Malezieux-Picard A, Nasce A, Azurmendi L, Pagano S, Vuilleumier N, Sanchez JC, et al. Kinetics of inflammatory biomarkers to predict one-year mortality in older patients hospitalized for pneumonia: a multivariable analysis. Int J Infect Dis. 2022;122:63–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">35550179</ArticleId></ArticleIdList></Reference><Reference><Citation>Levitt DG, Levitt MD. Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. Int J Gen Med. 2016;9:229–55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4956071</ArticleId><ArticleId IdType="pubmed">27486341</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Yang X, Yang J, Wen X, Wu S, Cui L. High levels of high-sensitivity C reactive protein to albumin ratio can increase the risk of cardiovascular disease. J Epidemiol Community Health. 2023;77(11):721–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10579461</ArticleId><ArticleId IdType="pubmed">37562809</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer. 2004;90(9):1704–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2409737</ArticleId><ArticleId IdType="pubmed">15150622</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang HS, Cho KW, Kwon SS, Kim YH. Prognostic significance of Glasgow prognostic score in patients with acute exacerbation of idiopathic pulmonary fibrosis. Respirology. 2018;23(2):206–12.</Citation><ArticleIdList><ArticleId IdType="pubmed">29024319</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuluozturk M, Deveci F. The Glasgow prognostic score can be a predictor of mortality in acute exacerbation of chronic obstructive pulmonary disease. Expert Rev Respir Med. 2020;14(5):521–5.</Citation><ArticleIdList><ArticleId IdType="pubmed">32093491</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, Wen X, Huang C, Liang Y, Mo Y, Xue L. Association between inflammation-based prognostic scores and in-hospital outcomes in elderly patients with acute myocardial infarction. Clin Interv Aging. 2019;14:1199–206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6615021</ArticleId><ArticleId IdType="pubmed">31308643</ArticleId></ArticleIdList></Reference><Reference><Citation>Altay S, Gurdogan M, Keskin M, Kardas F, Cakir B. The inflammation-based glasgow prognostic score as a prognostic factor in patients with intensive cardiovascular care unit. Medicina (Kaunas). 2019;55(5):139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6572028</ArticleId><ArticleId IdType="pubmed">31096693</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkman DN, Aquino M, Claessen BE, Baber U, Guedeney P, Sorrentino S, et al. Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions. Eur Heart J. 2018;39(46):4101–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30358832</ArticleId></ArticleIdList></Reference><Reference><Citation>Proctor MJ, Morrison DS, Talwar D, Balmer SM, O’Reilly DS, Foulis AK, et al. An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study. Br J Cancer. 2011;104(4):726–34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3049591</ArticleId><ArticleId IdType="pubmed">21266974</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui X, Jia Z, Chen D, Xu C, Yang P. The prognostic value of the C-reactive protein to albumin ratio in cancer: an updated meta-analysis. Medicine (Baltimore). 2020;99(14):e19165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7220550</ArticleId><ArticleId IdType="pubmed">32243358</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrerizo S, Cuadras D, Gomez-Busto F, Artaza-Artabe I, Marin-Ciancas F, Malafarina V. Serum albumin and health in older people: review and meta analysis. Maturitas. 2015;81(1):17–27.</Citation><ArticleIdList><ArticleId IdType="pubmed">25782627</ArticleId></ArticleIdList></Reference><Reference><Citation>Carella M, Porreca A, Piazza C, Gervasi F, Magro D, Venezia M, et al. Could the combination of eGFR and mGPS facilitate the differential diagnosis of age-related renal decline from diseases? A large study on the population of Western Sicily. J Clin Med. 2023;12(23):7352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10707716</ArticleId><ArticleId IdType="pubmed">38068404</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanetti M, Marzaro G, De Colle P, Toigo G, Bianchini D, Nastri M, et al. Predictors of short- and long-term mortality among acutely admitted older patients: role of inflammation and frailty. Aging Clin Exp Res. 2022;34(2):409–18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8847174</ArticleId><ArticleId IdType="pubmed">34255297</ArticleId></ArticleIdList></Reference><Reference><Citation>Baune BT, Rothermundt M, Ladwig KH, Meisinger C, Berger K. Systemic inflammation (Interleukin 6) predicts all-cause mortality in men: results from a 9-year follow-up of the MEMO Study. Age (Dordr). 2011;33(2):209–17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3127470</ArticleId><ArticleId IdType="pubmed">20617391</ArticleId></ArticleIdList></Reference><Reference><Citation>Bustacchini S, Abbatecola AM, Bonfigli AR, Chiatti C, Corsonello A, Di Stefano G, et al. The Report-AGE project: a permanent epidemiological observatory to identify clinical and biological markers of health outcomes in elderly hospitalized patients in Italy. Aging Clin Exp Res. 2015;27(6):893–901.</Citation><ArticleIdList><ArticleId IdType="pubmed">25809054</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray LC, Beattie E, Boscart VM, Henderson A, Hornby-Turner YC, Hubbard RE, et al. Development and testing of the interRAI acute care: a standardized assessment administered by nurses for patients admitted to acute care. Health Serv Insights. 2018;11:1178632918818836.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6299328</ArticleId><ArticleId IdType="pubmed">30618486</ArticleId></ArticleIdList></Reference><Reference><Citation>Corsonello A, Soraci L, Di Rosa M, Bustacchini S, Bonfigli AR, Lisa R, et al. Prognostic interplay of functional status and multimorbidity among older patients discharged from hospital. J Am Med Dir Assoc. 2022;23(3):499-506 e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">34384766</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberger M, Samsa GP, Schmader K, Greenberg SM, Carr DB, Wildman DS. Comparing proxy and patients’ perceptions of patients’ functional status: results from an outpatient geriatric clinic. J Am Geriatr Soc. 1992;40(6):585–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">1587975</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaeffner ES, Ebert N, Delanaye P, Frei U, Gaedeke J, Jakob O, et al. Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med. 2012;157(7):471–81.</Citation><ArticleIdList><ArticleId IdType="pubmed">23027318</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer. 2003;89(6):1028–30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2376960</ArticleId><ArticleId IdType="pubmed">12966420</ArticleId></ArticleIdList></Reference><Reference><Citation>Pencina MJ, D’Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30(1):11–21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3341973</ArticleId><ArticleId IdType="pubmed">21204120</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Rosa M, Sabbatinelli J, Soraci L, Corsonello A, Bonfigli AR, Cherubini A, et al. Neutrophil-to-lymphocyte ratio (NLR) predicts mortality in hospitalized geriatric patients independent of the admission diagnosis: a multicenter prospective cohort study. J Transl Med. 2023;21(1):835.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10664513</ArticleId><ArticleId IdType="pubmed">37990223</ArticleId></ArticleIdList></Reference><Reference><Citation>Trial J, Potempa LA, Entman ML. The role of C-reactive protein in innate and acquired inflammation: new perspectives. Inflamm Cell Signal. 2016;3(2):e1409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5058362</ArticleId><ArticleId IdType="pubmed">27738646</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurniawan RB, Oktafia P, Saputra PBT, Purwati DD, Saputra ME, Maghfirah I, et al. The roles of C-reactive protein-albumin ratio as a novel prognostic biomarker in heart failure patients: a systematic review. Curr Probl Cardiol. 2024;49(5):102475.</Citation><ArticleIdList><ArticleId IdType="pubmed">38401823</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B, Lv D. Prognostic value of C-reactive protein to albumin ratio for mortality in acute kidney injury. BMC Nephrol. 2023;24(1):44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9960151</ArticleId><ArticleId IdType="pubmed">36829136</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen S, Xiao Y. Association between C-reactive protein and albumin ratios and risk of mortality in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2023;18:2289–303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10590598</ArticleId><ArticleId IdType="pubmed">37873518</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao M, Zhang C, Gao L, Sun S, Song L, Liu S. Association between C-reactive protein-albumin ratio and overall survival in Parkinson’s disease using publicly available data: a retrospective cohort study. Heliyon. 2023;9(2):e12671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9898616</ArticleId><ArticleId IdType="pubmed">36747520</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang CL, Fan K, Gao MQ, Pang B. Prognostic value of glasgow prognostic score in non-small cell lung cancer: a systematic review and meta-analysis. Pathol Oncol Res. 2022;28:1610109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8885527</ArticleId><ArticleId IdType="pubmed">35241974</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamagata K, Fukuzawa S, Ishibashi-Kanno N, Uchida F, Bukawa H. Association between the C-reactive protein/albumin ratio and prognosis in patients with oral squamous cell carcinoma. Sci Rep. 2021;11(1):5446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7940640</ArticleId><ArticleId IdType="pubmed">33686103</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranzani OT, Zampieri FG, Forte DN, Azevedo LC, Park M. C-reactive protein/albumin ratio predicts 90-day mortality of septic patients. PLoS ONE. 2013;8(3):e59321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3595283</ArticleId><ArticleId IdType="pubmed">23555017</ArticleId></ArticleIdList></Reference><Reference><Citation>Altun Y, Balci HD. Evaluation of laboratory parameters as predictors of mortality. Clin Lab. 2024;70(4):664–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">38623656</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayranci MK, Kucukceran K, Dundar ZD. NLR and CRP to albumin ratio as a predictor of in-hospital mortality in the geriatric ED patients. Am J Emerg Med. 2021;44:50–5.</Citation><ArticleIdList><ArticleId IdType="pubmed">33578332</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonacera A, Stancanelli B, Colaci M, Malatino L. Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases. Int J Mol Sci. 2022;23(7):3636.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8998851</ArticleId><ArticleId IdType="pubmed">35408994</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheinenzon A, Shehadeh M, Michelis R, Shaoul E, Ronen O. Serum albumin levels and inflammation. Int J Biol Macromol. 2021;184:857–62.</Citation><ArticleIdList><ArticleId IdType="pubmed">34181998</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon EH, Peel NM, Samanta M, Theou O, Howlett SE, Hubbard RE. Sex differences in frailty: a systematic review and meta-analysis. Exp Gerontol. 2017;89:30–40.</Citation><ArticleIdList><ArticleId IdType="pubmed">28043934</ArticleId></ArticleIdList></Reference><Reference><Citation>Merrheim J, Villegas J, Van Wassenhove J, Khansa R, Berrih-Aknin S, le Panse R, et al. Estrogen, estrogen-like molecules and autoimmune diseases. Autoimmun Rev. 2020;19(3):102468.</Citation><ArticleIdList><ArticleId IdType="pubmed">31927086</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivieri F, Marchegiani F, Matacchione G, Giuliani A, Ramini D, Fazioli F, et al. Sex/gender-related differences in inflammaging. Mech Ageing Dev. 2023;211:111792.</Citation><ArticleIdList><ArticleId IdType="pubmed">36806605</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonafe M, Olivieri F, Cavallone L, Giovagnetti S, Mayegiani F, Cardelli M, et al. A gender–dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur J Immunol. 2001;31(8):2357–61.</Citation><ArticleIdList><ArticleId IdType="pubmed">11500818</ArticleId></ArticleIdList></Reference><Reference><Citation>Marquez EJ, Chung CH, Marches R, Rossi RJ, Nehar-Belaid D, Eroglu A, et al. Sexual-dimorphism in human immune system aging. Nat Commun. 2020;11(1):751.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7005316</ArticleId><ArticleId IdType="pubmed">32029736</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>